Arrhythmogenic right ventricular cardiomyopathy
MONDO:0016587Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that consists in progressive dystrophy of primarily the right ventricular myocardium with fibro-fatty replacement and ventricular dilation, and that is clinically characterized by ventricular arrhythmias and a risk of sudden cardiac death.
Also known as: ARVD, arrhythmogenic RVD, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, right ventricular dysplasia
38 clinical trials for this condition and its sub-types, 29 tagged with Arrhythmogenic right ventricular cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Arrhythmogenic right ventricular cardiomyopathy
-
Familial isolated arrhythmogenic right ventricular dysplasia 0 trials · 10 incl. sub-types
16 sub-types
- Arrhythmogenic right ventricular dysplasia 9 5 trials
- Arrhythmogenic right ventricular dysplasia 1 3 trials
- Familial isolated arrhythmogenic ventricular dysplasia, left dominant form 3 trials
- Catecholaminergic polymorphic ventricular tachycardia 1 2 trials
- Arrhythmogenic right ventricular dysplasia 10 0 trials
- Arrhythmogenic right ventricular dysplasia 11 0 trials
- Arrhythmogenic right ventricular dysplasia 12 0 trials
- Arrhythmogenic right ventricular dysplasia 13 0 trials
- Arrhythmogenic right ventricular dysplasia 3 0 trials
- Arrhythmogenic right ventricular dysplasia 4 0 trials
- Arrhythmogenic right ventricular dysplasia 5 0 trials
- Arrhythmogenic right ventricular dysplasia 6 0 trials
- Arrhythmogenic right ventricular dysplasia 8 0 trials
- Arrhythmogenic right ventricular dysplasia, familial, 14 0 trials
- Familial isolated arrhythmogenic ventricular dysplasia, biventricular form 0 trials
- Familial isolated arrhythmogenic ventricular dysplasia, right dominant form 0 trials
-
Naxos disease 0 trials
-
Could supervised exercise be safe for High-Risk heart patients?
Symptom relief Not yet recruitingThis trial investigates whether a structured, moderate-intensity cardiac rehabilitation program is safe for people with arrhythmogenic cardiomyopathy who carry high-risk genetic mutations. Participants will be randomly assigned to either the exercise program or standard physical …
Sponsor: Juan Jiménez Jáimez • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Heart device data may unlock secrets of rare heart muscle disease
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 300 people with arrhythmogenic cardiomyopathy who have an implantable cardioverter-defibrillator (ICD) and have had dangerous heart rhythms. Researchers want to count how often ICD-related problems occur, such as lead failure or ina…
Sponsor: Policlinico Casilino ASL RMB • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC